All Stories

  1. Assessing Impact of Data Quality in Early Post-Operative Glioblastoma Segmentation
  2. Reliable cognitive changes the first year following guideline-based treatment of IDH mutated gliomas: a longitudinal multicenter study
  3. Assessing Brain Injury After Extra-Axial Brain Tumor Resection: Circulating Neurofilament Light Levels, Neurological Deficits, and Fatigue
  4. Brain Metastasis Screening Strategies in relation to Neurological Symptoms in Stage IV Lung Adenocarcinoma
  5. Disparities in end-of-life care and place of death in people with malignant brain tumors—A Swedish registry study
  6. Functional outcome after introduction of hemilaminectomy in management of spinal schwannomas and meningiomas
  7. The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase–Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3
  8. Global health status and fatigue score in isocitrate dehydrogenase-mutant diffuse glioma grades 2 and 3: A longitudinal population-based study from surgery to 12-month follow-up
  9. The glymphatic system for neurosurgeons: a scoping review
  10. Clinical application of machine-based deep learning in patients with radiologically presumed adult-type diffuse glioma grades 2 or 3
  11. Intraoperative molecular diagnosis of glioma through combination of radiofrequency signals from ultrasound and deep learning
  12. Data from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  13. Data from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  14. Figure S1 from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  15. Figure S1 from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  16. Figure S2 from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  17. Figure S2 from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  18. Figure S3 from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  19. Figure S3 from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  20. Figure S4 from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  21. Figure S4 from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  22. Supplementary table from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  23. Supplementary table from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  24. Overview and recent advances in incidental meningioma
  25. Meningioma classification by immunohistochemistry: A replicability study
  26. Is intracranial volume a risk factor for IDH-mutant low-grade glioma? A case–control study
  27. Methodological Approaches to Ketogenic Dietary Treatments in Glioma Patients from a Nutritional Point of View
  28. A Feasibility Study on Deep Learning Based Brain Tumor Segmentation Using 2D Ellipse Box Areas
  29. Deep learning for automatic brain tumour segmentation on MRI: evaluation of recommended reporting criteria via a reproduction and replication study
  30. Experiences of language and communication after brain-tumour treatment: A long-term follow-up after glioma surgery
  31. Machine learning for cell classification and neighborhood analysis in glioma tissue
  32. Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort study
  33. Machine learning for cell classification and neighborhood analysis in glioma tissue
  34. Preoperative Patient-Reported Outcomes in Suspected Low-Grade Glioma: Markers of Disease Severity and Correlations with Molecular Subtypes
  35. Health-related quality of life and emotional well-being in patients with glioblastoma and their relatives
  36. Return to work following diagnosis of low-grade glioma
  37. Domain Mapping and Deep Learning from Multiple MRI Clinical Datasets for Prediction of Molecular Subtypes in Low Grade Gliomas
  38. The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study
  39. Short-term outcome following surgery for rare brain tumor entities in adults: a Swedish nation-wide registry-based study and comparison with SEER database
  40. Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee
  41. Preoperative antibiotic prophylaxis regimen in brain tumour surgery in Sweden: a quasi-experimental study
  42. Advancements in predicting outcomes in patients with glioma: a surgical perspective
  43. Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients
  44. Accuracy and complication rates of external ventricular drain placement with twist drill and bolt system versus standard trephine and tunnelation: a retrospective population-based study
  45. Indications and outcome in surgically treated asymptomatic meningiomas: a single-center case-control study
  46. Intraoperative 3D ultrasound–guided resection of diffuse low-grade gliomas: radiological and clinical results
  47. Is the anatomical distribution of low-grade gliomas linked to regions of gliogenesis?
  48. Tonn, Reardon, Rutka and Westphal (eds): Oncology of CNS Tumors
  49. Perioperative fatigue in patients with diffuse glioma
  50. Spatial distribution of malignant transformation in patients with low-grade glioma
  51. Enlarged Training Dataset by Pairwise GANs for Molecular-Based Brain Tumor Classification
  52. Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study
  53. Does preoperative health-related quality of life predict survival in high-grade glioma patients? – a prospective study
  54. The influence of irrigation fluid temperature on recurrence in the evacuation of chronic subdural hematoma
  55. Safe handling of veins in the pineal region—a mixed method study
  56. Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
  57. Cross-Modality Augmentation of Brain Mr Images Using a Novel Pairwise Generative Adversarial Network for Enhanced Glioma Classification
  58. Multiscale Deep Convolutional Networks for Characterization and Detection of Alzheimer’s Disease Using MR images
  59. The risk of ventricular catheter misplacement and intracerebral hemorrhage in shunt surgery for hydrocephalus
  60. Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma
  61. Multi-stream multi-scale deep convolutional networks for Alzheimer’s disease detection using MR images
  62. Clinical Course in Chronic Subdural Hematoma Patients Aged 18–49 Compared to Patients 50 Years and Above: A Multicenter Study and Meta-Analysis
  63. Surgical experience of neurosurgical residents in Europe: an alarming trend
  64. Radiological evaluation of low-grade glioma: time to embrace quantitative data?
  65. Short-Term Surgical Outcome for Vestibular Schwannoma in Sweden: A Nation-Wide Registry Study
  66. Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based study
  67. Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
  68. Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas
  69. Brain atlas for assessing the impact of tumor location on perioperative quality of life in patients with high-grade glioma: A prospective population-based cohort study
  70. Multi-stream Convolutional Autoencoder and 2D Generative Adversarial Network for Glioma Classification
  71. Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial
  72. Proton therapy for low-grade gliomas in adults: A systematic review
  73. 3D Multi-Scale Convolutional Networks for Glioma Grading Using MR Images
  74. Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population-based study
  75. Perioperative and Postoperative Quality of Life in Patients with Glioma–A Longitudinal Cohort Study
  76. Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study
  77. Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015
  78. Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging
  79. When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo
  80. Deep Learning and Multi-Sensor Fusion for Glioma Classification Using Multistream 2D Convolutional Networks
  81. Age and surgical outcome of low-grade glioma in Sweden
  82. Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications
  83. Scandinavian Multicenter Acute Subdural Hematoma (SMASH) Study: Study Protocol for a Multinational Population-Based Consecutive Cohort
  84. The Role of Angiotensin-Converting Enzyme Inhibitors in Patients with Chronic Subdural Hematoma: A Scandinavian Population-Based Multicenter Study
  85. Pre- and postoperative headache in patients with intracranial tumors
  86. The Diagnostic Properties of Intraoperative Ultrasound in Glioma Surgery and Factors Associated with Gross Total Tumor Resection
  87. When Are Complications After Brain Tumor Surgery Detected?
  88. An efficient 3D deep convolutional network for Alzheimer's disease diagnosis using MR images
  89. Does risk of brain cancer increase with intracranial volume? A population-based case control study
  90. Letter to the Editor. Usefulness of 5-ALA in resection of intracranial meningiomas
  91. Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
  92. Quantitative texture analysis in the prediction of IDH status in low-grade gliomas
  93. Post-surgical effects on language in patients with presumed low-grade glioma
  94. Pre-operative language ability in patients with presumed low-grade glioma
  95. Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases
  96. The Swedish study of Irrigation-fluid temperature in the evacuation of Chronic subdural hematoma (SIC!): study protocol for a multicenter randomized controlled trial
  97. Predictors of Recurrence and Complications After Chronic Subdural Hematoma Surgery: A Population-Based Study
  98. Role of antithrombotic therapy in the risk of hematoma recurrence and thromboembolism after chronic subdural hematoma evacuation: a population-based consecutive cohort study
  99. Tumor Volume Assessment in Low-Grade Gliomas: A Comparison of Preoperative Magnetic Resonance Imaging to Coregistered Intraoperative 3-Dimensional Ultrasound Recordings
  100. Assessment of drainage techniques for evacuation of chronic subdural hematoma: a consecutive population-based comparative cohort study
  101. Neurosurgery practice Questions and Answers, 2nd ed. (2016) Editor Shaya et al.
  102. Surgical resection versus watchful waiting in low-grade gliomas
  103. Does Pretreatment Tumor Growth Hold Prognostic Information for Patients with Glioblastoma?
  104. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review
  105. Surgery for chronic subdural hematoma in nonagenarians: A Scandinavian population-based multicenter study
  106. Accuracy of operating neurosurgeons' prediction of functional levels after intracranial tumor surgery
  107. Lumbar microdiscectomy for sciatica in adolescents: a multicentre observational registry-based study
  108. Clinical Presentation in Diffuse Low-Grade Gliomas
  109. Is there a response shift in generic health-related quality of life 6 months after glioma surgery?
  110. Right or left-sided brain tumor - does it matter?
  111. Surgical management of lumbar spinal stenosis: a survey among Norwegian spine surgeons
  112. Intra-rater variability in low-grade glioma segmentation
  113. Surgery for Lumbar Spinal Stenosis in Individuals Aged 80 and Older: A Multicenter Observational Study
  114. Standardized reporting of adverse events after microvascular decompression of cranial nerves; a population-based single-institution consecutive series
  115. Hyperbaric oxygen therapy in spontaneous brain abscess patients: a population-based comparative cohort study
  116. Quality of survival the 1st year with glioblastoma: a longitudinal study of patient-reported quality of life
  117. Venous Thromboembolism Prophylaxis in Meningioma Surgery: A Population-Based Comparative Effectiveness Study of Routine Mechanical Prophylaxis with or without Preoperative Low-Molecular-Weight Heparin
  118. Is There an Association Between Radiological Severity of Lumbar Spinal Stenosis and Disability, Pain, or Surgical Outcome?
  119. Risk of intracranial hemorrhage in users of oral antithrombotic drugs: Study protocol for a nationwide study
  120. Does Obesity Affect Outcomes After Decompressive Surgery for Lumbar Spinal Stenosis? A Multicenter, Observational, Registry-Based Study
  121. The Risk of Getting Worse: Predictors of Deterioration After Decompressive Surgery for Lumbar Spinal Stenosis: A Multicenter Observational Study
  122. Morbidity after intracranial tumor surgery: sensitivity and specificity of retrospective review of medical records compared with patient-reported outcomes at 30 days
  123. Editorial: Patient validation of retrospective data
  124. Perioperative quality of life in functionally dependent glioblastoma patients: A prospective study
  125. Microsurgical decompression for central lumbar spinal stenosis: a single-center observational study
  126. Does daily tobacco smoking affect outcomes after microdecompression for degenerative central lumbar spinal stenosis? – A multicenter observational registry-based study
  127. Predictors of Severe Complications in Intracranial Meningioma Surgery: A Population-Based Multicenter Study
  128. Minimally invasive decompression versus open laminectomy for central stenosis of the lumbar spine: pragmatic comparative effectiveness study
  129. The risk of ventricular catheter misplacement and intracerebral hemorrhage in shunt surgery for hydrocephalus
  130. Surgical Management of Eloquent Supratentorial Low-Grade Gliomas with Special Emphasis on Intraoperative Imaging
  131. Is duration of surgery a risk factor for extracranial complications and surgical site infections after intracranial tumor operations?
  132. The case for duraplasty in adults undergoing posterior fossa decompression for Chiari I malformation: A systematic review and meta-analysis of observational studies
  133. Scientific Alchemy and Proposed Gold Standards of Care
  134. Three-Dimensional Ultrasound–Guided Placement of Ventricular Catheters
  135. Surgical strategies in low-grade gliomas and implications for long-term quality of life
  136. Surgically Acquired Deficits and Diffusion Weighted MRI Changes after Glioma Resection - A Matched Case-Control Study with Blinded Neuroradiological Assessment
  137. Incidence Rates and Surgery of Primary Intraspinal Tumors in the Era of Modern Neuroimaging
  138. Effects of cerebral magnetic resonance imaging in outpatients on observed incidence of intracranial tumors and patient survival: a national observational study
  139. Animal study assessing safety of an acoustic coupling fluid that holds the potential to avoid surgically induced artifacts in 3D ultrasound guided operations
  140. Glioblastoma resection: in search of a threshold between worthwhile and futile
  141. Comparative effectiveness of microdecompression and laminectomy for central lumbar spinal stenosis: study protocol for an observational study
  142. Validation of model-guided placement of external ventricular drains
  143. Placement of External Ventricular Drains Using an Average Model
  144. Quality of life assessed with EQ-5D in patients undergoing glioma surgery: What is the responsiveness and minimal clinically important difference?
  145. Letter to the Editor: Diffuse low-grade gliomas
  146. Letter to the Editor: Microelectrode recording and deep brain stimulation
  147. “No growth” on serial MRI scans of a low grade glioma?
  148. Surgical strategy in grade II astrocytoma: a population-based analysis of survival and morbidity with a strategy of early resection as compared to watchful waiting
  149. Ultrasound imaging in neurosurgery: approaches to minimize surgically induced image artefacts for improved resection control
  150. Evidence-based clinical management and utilization of new technology in European neurosurgery
  151. Differentiating Diffuse World Health Organization Grade II and IV Astrocytomas With Ex Vivo Magnetic Resonance Spectroscopy
  152. Venous complications in supracerebellar infratentorial approach
  153. Risiko og nytte ved hjernesvulstoperasjoner
  154. Model-Guided Placement of Cerebral Ventricular Catheters
  155. Low Grade Gliomas in Eloquent Locations – Implications for Surgical Strategy, Survival and Long Term Quality of Life
  156. Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas
  157. Survival and Treatment Patterns of Glioblastoma in the Elderly: A Population-Based Study
  158. The influence of surgery on quality of life in patients with intracranial meningiomas: a prospective study
  159. Letter to the editor: Glioblastoma resection
  160. Editorial
  161. Incidence and causes of perioperative mortality after primary surgery for intracranial tumors: a national, population-based study
  162. Patient selection and clinical outcomes in patients operated for brain metastases – is specialty of the referring physicians a prognostic factor?
  163. Assessment of referrals to a multidisciplinary outpatient clinic for patients with back pain
  164. An adolescent with suspected intracranial hypertension—ALL is not what it seems
  165. Postoperative Deterioration in Health Related Quality of Life as Predictor for Survival in Patients with Glioblastoma: A Prospective Study
  166. The Risk of Getting Worse: Surgically Acquired Deficits, Perioperative Complications, and Functional Outcomes After Primary Resection of Glioblastoma
  167. Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score
  168. A new system for 3D ultrasound-guided placement of cerebral ventricle catheters
  169. Quality of life in patients with intracranial gliomas: the impact of modern image-guided surgery
  170. Clinical outcomes and safety assessment in elderly patients undergoing decompressive laminectomy for lumbar spinal stenosis: a prospective study
  171. Ultrasound-guided operations in unselected high-grade gliomas—overall results, impact of image quality and patient selection
  172. Five-year outcome after mild head injury: a prospective controlled study